Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Aquestive Therapeutics COO Exercises Warrant for 4,587 Shares

Cassie Jung, Chief Operating Officer of Aquestive Therapeutics, Inc. (NASDAQ:AQST), filed a Form 4 on September 8, 2026, disclosing the exercise of a Common Stock Purchase Warrant on September 3, 2026.

Vinay Lochav | 08 September 2026

Live Oak Bancshares CEO Sells 10,000 Shares Under 10b5-1 Plan

James S. Mahan III, Chief Executive Officer and Director of Live Oak Bancshares, Inc., filed a Form 4 on September 8, 2026, disclosing the sale of 10,000 shares of Voting Common Stock on September 3, 2026, pursuant to a Rule 10b5-1 trading plan.

Manish Choudhary | 08 September 2026

Hershey Trust Sells Over 18,000 HSY Shares in Two Days

Hershey Trust Co, acting as trustee for Milton Hershey School, filed a Form 4 with the SEC on September 8, 2026, disclosing the sale of 18,000 shares of Hershey Co common stock across seven transactions on September 3 and September 4, 2026, pursuant to …

Shwetambri Chauhan | 08 September 2026

Live Oak Bancshares Director Sells 1,600 Shares

Director Tonya Williams Bradford filed a Form 4 with the SEC on September 8, 2026, reporting the sale of 1,600 shares of Live Oak Bancshares, Inc. voting common stock on September 3, 2026.

Aakashdeep | 08 September 2026

Allstate EVP Zulfikar Jeevanjee Reports Stock Award Conversion

Zulfikar Jeevanjee, Executive Vice President and Chief Technology Officer of AIC at The Allstate Corporation, filed a Statement of Changes in Beneficial Ownership on September 8, 2026, reporting two transactions in Allstate common stock dated September 6, 2026.

Manish Choudhary | 08 September 2026

Live Oak Bancshares Director Sells 6,590 Shares

Director William L. Williams III filed a Form 4 with the SEC on September 8, 2026, reporting the sale of 6,590 shares of Live Oak Bancshares, Inc. voting common stock on September 3, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Aakashdeep | 08 September 2026

Opus Genetics CFO Sells 28,000 Shares of Common Stock

Robert E. Gagnon, Chief Financial Officer of Opus Genetics, Inc. (NASDAQ:IRD), filed a Form 4 on September 8, 2026, disclosing the sale of 28,000 shares of common stock on September 3, 2026.

Anjali Anand | 08 September 2026

Opus Genetics Director Exercises Warrant for 784,314 Shares

Director Cam Gallagher filed a Form 4 with the SEC on September 8, 2026, reporting the exercise of a warrant to acquire 784,314 shares of Opus Genetics, Inc. common stock at $1.15 per share, along with entry into a 180-day lock-up agreement with the …

Anjali Anand | 08 September 2026

Allstate Director Margaret Keane Disposes 944 Shares

Director Margaret M. Keane filed a Form 4 with the SEC on September 8, 2026, reporting a disposition of 944 shares of Allstate Corp common stock on September 3, 2026.

Nitish Kishor | 08 September 2026

Dynatrace Director Reports RSU Vesting Transaction

A statement of changes in beneficial ownership filed on September 8, 2026, disclosed that Lisa M. Campbell, a director of Dynatrace, Inc., acquired 506 shares of common stock through the vesting of restricted stock units on September 4, 2026.

Nitish Kishor | 08 September 2026
Support

Hi! How can we help you today?

Loading…